Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients (Q57834176)

4

object named as

Henry L. Butt

0 references

author name string

Christopher W. Armstrong

1

0 references

Neil R. McGregor

2

0 references

Donald P. Lewis

NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome

3

0 references

publication date

30 May 2015

0 references

published in

Metabolomics

0 references

volume

11

0 references

issue

6

0 references

page(s)

1626-1639

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Coping and illness cognitions: chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Hyperglycemia in critical illness: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Viral serologies in patients with chronic fatigue and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Glutamate is a positive autocrine signal for glucagon release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

A randomised controlled trial of a psycho-educational intervention to aid recovery in infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Argininosuccinate synthase as a novel biomarker for inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Myalgic encephalomyelitis: International Consensus Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

A review of the definitional criteria for chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

The complex mechanism of glutamate dehydrogenase in insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Association of Mitochondrial Dysfunction and Fatigue: A Review of the Literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Chronic fatigue syndrome: new evidence for a central fatigue disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Chronic fatigue syndrome: a working case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

A community-based study of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Chronic fatigue syndrome: reviewing the research findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Urinary and plasma organic acids and amino acids in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

A sample preparation protocol for 1H nuclear magnetic resonance studies of water-soluble metabolites in blood and urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Stress hyperglycemia, insulin treatment, and innate immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5

Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11306-015-0816-5